Elevated ZC3H15 increases HCC growth and predicts poor survival after surgical resection

Oncotarget

Volumn 7, Issue 24, 2016, Pages 37238-37249

  Jiang, Bei Ge ^a   Wan, Zheng Hua ^a   Huang, Jian ^a   Li, Li Mei ^b   Liu, Hui ^a   Fu, Si Yuan ^a   Yang, Yuan ^a   Zhang, Jin ^a   Yuan, Shen Xian ^a   Wang, Ruo Yu ^a   Yang, Yun ^a   Gu, Fang Ming ^a   Dong, Li Wei ^a   Pan, Ze Ya ^a   Zhou, Wei Ping ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

Hepatocellular carcinoma; NF B; TRAF2; ZC3H15

Indexed keywords

ALPHA FETOPROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; TUMOR PROTEIN; UNCLASSIFIED DRUG; ZINC FINGER CCCH TYPE CONTAINING 15 PROTEIN; CARRIER PROTEIN; LEREPO4 PROTEIN, HUMAN; PSMD2 PROTEIN, HUMAN; SMALL INTERFERING RNA; TUMOR MARKER;

ADULT; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PREDICTION; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; TUMOR GENE; WESTERN BLOTTING; ZC3H15 GENE; BLOOD; GENE SILENCING; GENETICS; KAPLAN MEIER METHOD; LIVER TUMOR; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; SIGNAL TRANSDUCTION; TISSUE MICROARRAY; TUMOR INVASION;

ADULT; ALPHA-FETOPROTEINS; BIOMARKERS, TUMOR; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CARRIER PROTEINS; DISEASE-FREE SURVIVAL; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NF-KAPPA B; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TISSUE ARRAY ANALYSIS; TNF RECEPTOR-ASSOCIATED FACTOR 2;

EID: 84978034256     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.9361     Document Type: Article

References (31)

1. Kamangar F, Dores GM and Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006; 24:2137-2150.
2. El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012; 142:1264-1273 e1261.
3. Gao J, Xie L, Yang WS, Zhang W, Gao S, Wang J and Xiang YB. Risk factors of hepatocellular carcinoma- current status and perspectives. Asian Pac J Cancer Prev. 2012; 13:743-752.
4. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ and Thun MJ. Cancer statistics, 2005. CA Cancer J Clin. 2005; 55:10-30.
5. Lopez PM, Villanueva A and Llovet JM. Systematic review: evidence-based management of hepatocellular carcinoma- an updated analysis of randomized controlled trials. Aliment Pharmacol Ther. 2006; 23:1535-1547.
6. Pang RW, Joh JW, Johnson PJ, Monden M, Pawlik TM and Poon RT. Biology of hepatocellular carcinoma. Ann Surg Oncol. 2008; 15:962-971.
7. Yeo W, Mok TS, Zee B, Leung TW, Lai PB, Lau WY, Koh J, Mo FK, Yu SC, Chan AT, Hui P, Ma B, Lam KC, Ho WM, Wong HT, Tang A, et al. A randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma. J Natl Cancer Inst. 2005; 97:1532-1538.
8. Portolani N, Coniglio A, Ghidoni S, Giovanelli M, Benetti A, Tiberio GA and Giulini SM. Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Ann Surg. 2006; 243:229-235.
9. Leipe DD, Wolf YI, Koonin EV and Aravind L. Classification and evolution of P-loop GTPases and related ATPases. J Mol Biol. 2002; 317:41-72.
10. Li B and Trueb B. DRG represents a family of two closely related GTP-binding proteins. Biochim Biophys Acta. 2000; 1491:196-204.
11. Sazuka T, Tomooka Y, Ikawa Y, Noda M and Kumar S. DRG: a novel developmentally regulated GTPbinding protein. Biochem Biophys Res Commun. 1992; 189:363-370.
12. Daugeron MC, Prouteau M, Lacroute F and Seraphin B. The highly conserved eukaryotic DRG factors are required for efficient translation in a manner redundant with the putative RNA helicase Slh1. Nucleic Acids Res. 2011; 39:2221-2233.
13. Ishikawa K, Azuma S, Ikawa S, Semba K and Inoue J. Identification of DRG family regulatory proteins (DFRPs): specific regulation of DRG1 and DRG2. Genes Cells. 2005; 10:139-150.
14. Carrick DM, Lai WS and Blackshear PJ. The tandem CCCH zinc finger protein tristetraprolin and its relevance to cytokine mRNA turnover and arthritis. Arthritis Res Ther. 2004; 6:248-264.
15. Fleischer TC, Weaver CM, McAfee KJ, Jennings JL and Link AJ. Systematic identification and functional screens of uncharacterized proteins associated with eukaryotic ribosomal complexes. Genes Dev. 2006; 20:1294-1307.
16. Wout PK, Sattlegger E, Sullivan SM and Maddock JR. Saccharomyces cerevisiae Rbg1 protein and its binding partner Gir2 interact on Polyribosomes with Gcn1. Eukaryot Cell. 2009; 8:1061-1071.
17. Ishikawa K, Akiyama T, Ito K, Semba K and Inoue J. Independent stabilizations of polysomal Drg1/Dfrp1 complex and non-polysomal Drg2/Dfrp2 complex in mammalian cells. Biochem Biophys Res Commun. 2009; 390:552-556.
18. Ko MS, Lee UH, Kim SI, Kim HJ, Park JJ, Cha SJ, Kim SB, Song H, Chung DK, Han IS, Kwack K and Park JW. Overexpression of DRG2 suppresses the growth of Jurkat T cells but does not induce apoptosis. Arch Biochem Biophys. 2004; 422:137-144.
19. Song H, Kim SI, Ko MS, Kim HJ, Heo JC, Lee HJ, Lee HS, Han IS, Kwack K and Park JW. Overexpression of DRG2 increases G2/M phase cells and decreases sensitivity to nocodazole-induced apoptosis. J Biochem. 2004; 135:331-335.
20. Adachi E, Maehara S, Tsujita E, Taguchi K, Aishima S, Rikimaru T, Yamashita Y and Tanaka S. Clinicopathologic risk factors for recurrence after a curative hepatic resection for hepatocellular carcinoma. Surgery. 2002; 131:S148-152.
21. Kow AW, Kwon CH, Song S, Shin M, Kim JM and Joh JW. Risk factors of peritoneal recurrence and outcome of resected peritoneal recurrence after liver resection in hepatocellular carcinoma: review of 1222 cases of hepatectomy in a tertiary institution. Ann Surg Oncol. 2012; 19:2246-2255.
22. Park JH, Koh KC, Choi MS, Lee JH, Yoo BC, Paik SW, Rhee JC and Joh JW. Analysis of risk factors associated with early multinodular recurrences after hepatic resection for hepatocellular carcinoma. Am J Surg. 2006; 192:29-33.
23. Yamashita Y, Tsuijita E, Takeishi K, Fujiwara M, Kira S, Mori M, Aishima S, Taketomi A, Shirabe K, Ishida T and Maehara Y. Predictors for microinvasion of small hepatocellular carcinoma
24. Nanashima A, Tobinaga S, Kunizaki M, Miuma S, Taura N, Takeshita H, Hidaka S, Sawai T, Nakao K and Nagayasu T. Strategy of treatment for hepatocellular carcinomas with vascular infiltration in patients undergoing hepatectomy. J Surg Oncol. 2010; 101:557-563.
25. Luk JM, Lam CT, Siu AF, Lam BY, Ng IO, Hu MY, Che CM and Fan ST. Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values. Proteomics. 2006; 6:1049-1057.
26. Capalbo G, Mueller-Kuller T, Koschmieder S, Klein HU, Ottmann OG, Hoelzer D and Scheuring UJ. Characterization of ZC3H15 as a potential TRAF-2-interacting protein implicated in the NFkappaB pathway and overexpressed in AML. Int J Oncol. 2013; 43:246-254.
27. Pahl HL. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene. 1999; 18:6853-6866.
28. Aggarwal BB. Nuclear factor-kappaB: the enemy within. Cancer Cell. 2004; 6:203-208.
29. Dong LW, Hou YJ, Tan YX, Tang L, Pan YF, Wang M and Wang HY. Prognostic significance of Beclin 1 in intrahepatic cholangiocellular carcinoma. Autophagy. 2011; 7:1222-1229.
30. Wang Q, Tan YX, Ren YB, Dong LW, Xie ZF, Tang L, Cao D, Zhang WP, Hu HP and Wang HY. Zinc finger protein ZBTB20 expression is increased in hepatocellular carcinoma and associated with poor prognosis. BMC Cancer. 2011; 11:271.
31. Hou YJ, Dong LW, Tan YX, Yang GZ, Pan YF, Li Z, Tang L, Wang M, Wang Q and Wang HY. Inhibition of active autophagy induces apoptosis and increases chemosensitivity in cholangiocarcinoma. Lab Invest. 2011; 91:1146-1157.